ResMed (RMD) Tops Q3 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $240.51 --0%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
SENEA, XFOR, MG, More
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
SENEA, XFOR, MG, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.13, $0.20 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.17 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Frontdoor, Inc. (FTDR) Tops Q3 EPS by 4c ; Offers Guidance
- Middleby Corp (MIDD) Tops Q3 EPS by 31c, Beats on Revenue; Offers FY26 Guidance
- GEO Group (GEO) Tops Q3 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
